Table 1 of Amaral-Fernandes, Mol Vis 2011; 17:3175-3179.


Table 1. Summary of clinical and molecular data of the patients studied.

Patient/
gender
Age of
manifestation
Visual
acuity
Visual
fields
Familial
recurrence

Mutation
1/M 35 OD 20/200 Cecocentral - -
    OS 20/200 Cecocentral    
2/M 35 OD 20/100 Central - -
    OS 20/50 Central    
3/M 35 OD 20/100 Central - -
    OS cf at 1m Central    
4/M 47 OD 20/200 Cecocentral + T14484C
    OS 20/200 Cecocentral    
5/M 46 OD 20/50 Relative central scotoma - -
    OS 20/60 Relative central scotoma    
6/M 42 OD 20/200 Cecocentral - -
    OS 20/200 Cecocentral    
7/M 52 OD 20/200 Central - -
    OS 20/100 Central    
8/M 35 OD cf at 1m Fovea 4dB + G11778A
    OS cf at 1m Fovea 0dB    
9/M 46 OD 20/100 Central - -
    OS 20/100 Central    
10/M 38 OD 20/100 Central - -
    OS 20/100 Central    
11/M 43 OD cf at 1m Central - -
    OS cf at 1m Central    
12/M 44 OD 20/50 Relative central scotoma - -
    OS 20/50 Relative central scotoma    
13/M 41 OD 20/200 Fovea 9dB - -
    OS 20/200 Fovea 13dB    
14/M 52 OD cf at 1m Cecocentral - -
    OS cf at 1m Cecocentral    
15/M 27 OD cf at 1m Central + T14484C
    OS cf at 1m Central    
16/M 40 OD 20/50 Central - -
    OS 20/50 Central    
17/M 50 OD cf at 1m Fovea 5dB - -
    OS 20/200 Fovea 0dB    
18/M 44 OD cf at 1m Fovea 10dB - -
    OS cf at 1m Fovea 10dB    
19/M 17 OD 20/100 Central + -
    OS 20/200 Central    
20/M 41 OD 20/200 Central - -
    OS 20/50 Central    
21/M 29 OD 20/50 Central - -
    OS 20/50 Central    
22/M 40 OD 20/60 Central - -
    OS 20/100 Cecocentral    
23/M 33 OD 20/100 Central - -
    OS 20/100 Central    
24/M 38 OD 20/60 Central - -
    OS 20/60 Central    
25/M 17 OD cf at 1m Fovea 0dB - G11778A
    OS cf at 1m Cecocentral    
26/F 20 OD 20/50 Central - -
    OS 20/100 Cecocentral